Nanotechnology-Based Biosensors and Diagnostics: Technology Push versus Industrial/Healthcare Requirements

Leary, J. F. (2010). Nanotechnology: what is it and why is small so big? Canadian Journal of Ophthalmology, 45, 449–456.

Weiss, P. S. (2010). Nanoscience and nanotechnology: present and future. ACS Nano, 4, 1771–1772.

Jiarong, C., Yuqing, M., Nongyue, H., Xiaohua, W., Sijiao, L. (2004). Nanotechnology and biosensors. Biotechnology Advances, 22, 505–518.

Vaddiraju, S., Tomazos, I., Burgess, D. J., Jain, F. C., Papadimitrakopoulos, F. (2010). Emerging synergy between nanotechnology and implantable biosensors: a review. Biosensors and Bioelectronics, 25, 1553–1565.

Cheng, M. M. C., Cuda, G., Bunimovich, Y. L., et al. (2006). Nanotechnologies for biomolecular detection and medical diagnostics. Current Opinion in Chemical Biology, 10, 11–19.

Hauck, T. S., Giri, S., Gao, Y., Chan, W. C. W. (2010). Nanotechnology diagnostics for infectious diseases prevalent in developing countries. Advance Drug Delaware Review, 62, 438–448.

Sosnik, A., & Amiji, M. (2010). Nanotechnology solutions for infectious diseases in developing nations. Advance Drug Delaware Review, 62, 375–377.

Kim, P. S., Djazayeri, S., Zeineldi, R. (2011). Novel nanotechnology approaches to diagnosis and therapy of ovarian cancer. Gynecologic Oncology, 120, 393–403.

Stylios, G. K., Giannoudis, P. V., Wan, T. (2005). Applications of nanotechnologies in medical diagnostics. Injury, International Journal of the Care of the Injured, 36S, S6–S13.

Fournier-Wirth, C., Coste, J. (2010). Nanotechnologies for pathogen detection: future alternatives? Biologicals, 38, 9–13.

Ansari, A. A., Alhoshan, M., Alsalhi, M. S., Aldwayyan, A. S. (2010). Prospects of nanotechnology in clinical immunodiagnostics. Sensors, 10, 6535–6581.

Jain, K. K. (2005). Nanotechnology in clinical laboratory diagnostics. Clinica Chimica Acta, 358, 37–54.

Thomas, C. R., George, S., Horst, A. M., et al. (2011). Nanomaterials in the environment: from materials to high-throughput screening to organisms. ACS Nano, 5, 13–20.

Shi, J., Votruba, A. R., Farokhzad, O. C., Langer, R. (2010). Nanotechnology in drug delivery and tissue engineering: from discovery to applications. Nano Letters, 10, 3223–3230.

Vashist, S. K., Zheng, D., Pastorin, G., Al-Rubeaan, K., Luong, J. H. T., Sheu, F. S. (2011). Delivery of drugs and biomolecules using carbon nanotubes. Carbon, 49, 4077–4097.

Li, J., Yap, S. Q., Yoong, S. L., et al. (2012). Carbon nanotube bottles for incorporation, release and enhanced cytotoxic effect of cisplatin. Carbon, 50, 1625–1634.

Moghimi, S. M., Peer, D., Langer, R. (2011). Reshaping the future of nanopharmaceuticals: ad ludicum. ACS Nano, 5, 8454–8458.

Kim, K. Y. (2007). Nanotechnology platforms and physiological challenges for cancer therapeutics. Nanomedicine: Nanotechnology, Biology, and Medicine, 3, 103–110.

Misra, R., Acharya, S., Sahoo, S. K. (2010). Cancer nanotechnology: application of nanotechnology in cancer therapy. Drug Discovery Today, 15, 842–850.

Kawasaki, E. S., & Player, A. (2005). Nanotechnology, nanomedicine, and the development of new, effective therapies for cancer. Nanomedicine: Nanotechnology, Biology, and Medicine, 1, 101–109.

Farokhzad, O. C., & Langer, R. (2006). Nanomedicine: developing smarter therapeutic and diagnostic modalities. Adv Drug Del Rev, 58, 1456–1459.

Phan, J. H., Moffitt, R. A., Stokes, T. H., Liu, J., Young, A. N., Nie, S., et al. (2009). Convergence of biomarkers, bioinformatics and nanotechnology for individualized cancer treatment. Trends in Biotechnology, 27, 350–358.

Yan, Y., Such, G. K., Johnston, A. P. R., Best, J. P., Caruso, F. (2012). Engineering particles for therapeutic delivery: prospects and challenges. ACS Nano. doi: 10.1021/nn3016162 .

Fortina, P., Kricka, L. J., Bonnell, D., Kulkarni, A., Wang, J., Miyahara, Y., et al. (2010). Nanotechnology: improving clinical testing? Clinical Chemistry, 56, 1384–1389.

Zarbin, M. A., Montemagno, C., Leary, J. F., Ritch, R. (2010). Nanotechnology in ophthalmology. Canadian Journal of Ophthalmology, 45, 457–476.

Re, F., Gregori, M., Masserini, M. (2012). Nanotechnology for neurodegenerative disorders. Maturitas. doi: 10.1016/j.maturitas.2011.12.015 .

Sahoo, S. K., Parveen, S., Panda, J. J. (2007). The present and future of nanotechnology in human health care. Nanomedicine: Nanotechnology, Biology, and Medicine, 3, 20–31.

Brambilla, D., Droumaguet, B. L., Nicolas, J., et al. (2011). Nanotechnologies for Alzheimer’s disease: diagnosis, therapy, and safety issues. Nanomedicine: Nanotechnology, Biology, and Medicine, 7, 521–540.

Farrell, D., Alper, J., Ptak, K., Panaro, N. J., Grodzinski, P., Barker, A. D. (2010). Recent advances from the National Cancer Institute Alliance for Nanotechnology in Cancer. ACS Nano, 4, 589–594.

Retél, V. P., Hummel, M. J. M., Harten, W. H. V. (2009). Review on early technology assessments of nanotechnologies in oncology. Molecular Oncology, 3, 394–401.

Boisseau, P., & Loubaton, B. (2011). Nanomedicine, nanotechnology in medicine. Comptes Rendus Physique, 12, 620–636.

Sawhney, A. P. S., Condon, B., Singh, K. V., Pang, S. S., Li, G., Hui, D. (2008). Modern applications of nanotechnology in textiles. Textile Research Journal, 78, 731–739.

Duncan, T. V. (2011). Applications of nanotechnology in food packaging and food safety: barrier materials, antimicrobials and sensors. Journal of Colloid and Interface Science, 363, 1–24.

Sakamoto, J. H., Ven, A. L. V. D., Godin, B., et al. (2010). Enabling individualized therapy through nanotechnology. Pharmacological Research, 62, 57–89.

Bonnell, D. (2010). The next decade of nanoscience and nanotechnology. ACS Nano, 4, 6293–6294.

http://www.wtec.org/nano2/

Gabellieri, C. (2011). Nanomedicine in the European Commission policy for nanotechnology. Nanomedicine: Nanotechnology, Biology, and Medicine, 7, 519–520.

Horton, M. A., & Khan, A. (2006). Medical nanotechnology in the UK: a perspective from the London Centre for Nanotechnology. Nanomedicine: Nanotechnology, Biology, and Medicine, 2, 42–48.

Pandza, K., Wilkins, T. A., Alfoldi, E. A. (2011). Collaborative diversity in a nanotechnology innovation system: evidence from the EU framework programme. Technovation, 31, 476–489.

Allarakhia, M., & Walsh, S. (2012). Analyzing and organizing nanotechnology development: application of the institutional analysis development framework to nanotechnology consortia. Technovation, 32, 216–226.

http://www.gartner.com/technology/research/methodologies/hype-cycle.jsp

Service RF. (2001). Breakthrough of the year: molecules get wired. Science, 294, 2442–2443.

Service RF. (2002). Bell Labs fires star physicist found guilty of forging data. Science, 298, 30–31.

http://www.sciencemag.org/content/298/5595/961.2

Hersam, M. (2011). Nanoscience and nanotechnology in the posthype era. ACS Nano, 5, 1–2.

Gubala, V., Harris, L. F., Ricco, A. J., Tan, M. X., Williams, D. E. (2012). Point of care diagnostics: status and future. Analytical Chemistry, 84, 487–515.

Rasooly, A. (2006). Moving biosensors to point-of-care cancer diagnostics. Biosensors and Bioelectronics, 21, 1847–1850.

Frasco, M. F., & Chaniotakis, N. (2010). Bioconjugated quantum dots as fluorescent probes for bioanalytical applications. Analytical and Bioanalytical Chemistry, 396, 229–240.

Bruls, D. M., Evers, T. H., Kahlman, J. A. H., et al. (2009). Rapid integrated biosensor for multiplexed immunoassays based on actuated magnetic nanoparticles. Lab on a Chip, 9, 3504–3510.

Cheng, Y., Zhao, L., Li, Y., Xu, T. (2011). Design of biocompatible dendrimers for cancer diagnosis and therapy: current status and future perspectives. Chemical Society Reviews, 40, 2673–2703.

Ghazani, A. A., Lee, J. A., Klostranec, J., et al. (2006). High throughput quantification of protein expression of cancer antigens in tissue microarray using quantum dot nanocrystals. Nano Letters, 6, 2881–2886.

Kairemo, K., Erba, P., Bergström, K., Pauwels, E. K. J. (2008). Nanoparticles in cancer. Current Radiopharmaceuticals, 1, 30–36.

Bianco A., Kostarelos K., Partidos C.D., Prato M. (2005). Biomedical applications of functionalised carbon nanotubes. Chemical Communication, 571–577

Vashist, S. K., Zheng, D., Al-Rubeaan, K., Luong, J. H. T., Sheu, F. S. (2011). Advances in carbon nanotube based electrochemical sensors for bioanalytical applications. Biotechnology Advances, 29, 169–188.

Dresselhaus, M. S., & Araujo, P. T. (2010). The 2010 Nobel Prize in physics for graphene: some perspectives. ACS Nano, 4, 6297–6302.

Zheng, D., Vashist, S.K., Luong, J.H.T., Al-Rubeaan, K., Sheu, F.S. (2012). Amperometric glucose biosensing using 3-aminopropyltriethoxysilane functionalized graphene. Talanta, doi: 10.1016/j.talanta.2012.05.014 .

Azzazy, H. M. E., Mansour, M. M. H., Kazmierczak, S. C. (2007). From diagnostics to therapy: prospects of quantum dots. Clinical Biochemistry, 40, 917–927.

Parveen, S., Misra, R., Sahoo, S. K. (2012). Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging. Nanomedicine: Nanotechnology, Biology, and Medicine, 8, 147–166.

Fan, Z., Shelton, M., Singh, A. K., Senapati, D., Khan, S. A., Ray, P. C. (2012). Multifunctional plasmonic shell–magnetic core nanoparticles for targeted diagnostic, isolation, and photothermal destruction of tumor cells. ACS Nano, 6, 1065–1073.

Boisselier, E., & Astruc, D. (2009). Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity. Chemical Society Reviews, 38, 1759–1782.

Dreaden, E. C., Alkilany, A. M., Huang, X., Murphy, C. J., El-Sayed, M. A. (2012). The golden age: gold nanoparticles for biomedicine. Chemical Society Reviews, 41, 2740–2779.

Dykman, L., & Khlebtsov, N. (2012). Gold nanoparticles in biomedical applications: recent advances and perspectives. Chemical Society Reviews, 41, 2256–2282.

Misiakos, K., Kakabakos, S. E., Petrou, P. S., Ruf, H. H. (2004). A monolithic silicon optoelectronic transducer as a real-time affinity biosensor. Analytical Chemistry, 76, 1366–1373.

Weizmann, Y., Patolsky, F., Willner, I. (2001). Amplified detection of DNA and analysis of single-base mismatches by the catalyzed deposition of gold on Au-nanoparticles. Analyst, 126, 1502–1504.

Rosi, N. L., & Mirkin, C. A. (2005). Nanostructures in biodiagnostics. Chemical Reviews, 105, 1547–1562.

Lee, K., Drachev, V. P., Irudayaraj, J. (2011). DNA–gold nanoparticle reversible networks grown on cell surface marker sites: application in diagnostics. ACS Nano, 5, 2109–2117.

Koh, I., & Josephson, L. (2009). Magnetic nanoparticle sensors. Sensors, 9, 8130–8145.

Haun, J. B., Yoon, T.-J., Lee, H., Weissleder, R. (2010). Magnetic nanoparticle biosensors. WIREs Nanomedicine Nanobiotechnology, 2, 291–304.

Dittmer, W. U., de Kievit, P., Prins, M. W. J., Vissers, J. L. M., Mersch, M. E. C., Martens, M. F. W. C. (2008). Sensitive and rapid immunoassay for parathyroid hormone using magnetic particle labels and magnetic actuation. Journal of Immunological Methods, 338, 40–46.

Sashiwa, H., & Aiba, S.-I. (2004). Chemically modified chitin and chitosan as biomaterials. Progress in Polymer Science, 29, 887–908.

Koev, S. T., Dykstra, P. H., Luo, X., Rubloff, G. W., Bentley, W. E., Payne, G. F., et al. (2010). Chitosan: an integrative biomaterial for lab-on-a-chip devices. Lab on a Chip, 10, 3026–3042.

Kean, T., & Thanou, M. (2010). Biodegradation, biodistribution and toxicity of chitosan. Adv Drug Del Rev, 62, 3–11.

Satija, J., Sai, V. V. R., Mukherji, S. (2011). Dendrimers in biosensors: concepts and applications. Journal of Materials Chemistry, 21, 14367–14386.

Shen, M., & Shi, X. (2010). Dendrimer-based organic/inorganic hybrid nanoparticles in biomedical applications. Nanoscale, 2, 1596–1610.

Dennis, M., Vriezema, D. M., Aragonès, M. C., Elemans, J. A. A. W., Cornelissen, J. J. L. M., Rowan, A. E., et al. (2005). Self-assembled nanoreactors. Chemical Reviews, 105, 1445–1489.

Malam, Y., Loizidou, M., Seifalian, A. M. (2009). Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer. Trends in Pharmacological Sciences, 30, 592–599.

Christensen, S. M., & Stamou, D. (2007). Surface-based lipid vesicle reactor systems: fabrication and applications. Soft Matter, 3, 828–836.

Jelinek, R., & Kolusheva, S. (2007). Biomolecular sensing with colorimetric vesicles. Topics in Current Chemistry, 277, 155–180.

Leung, A. C. W., Hrapovic, S., Lam, E., Liu, Y., Male, K. B., Mahmoud, K. A., et al. (2011). Characteristics and properties of carboxylated cellulose nanocrystals prepared from a novel one-step procedure. Small, 7, 302–305.

Lam, E., Male, K. B., Chong, J. H., Leung, A. C. W., Luong, J. H. T. (2012). Applications of functionalized and nanoparticle-modified nanocrystalline cellulose. Trends in Biotechnology, 30, 283–290.

Shukla, G. C., Haque, F., Tor, Y., et al. (2011). A boost for the emerging field of RNA nanotechnology. ACS Nano, 5, 3405–3418.

Modi, S., Bhatia, D., Simmel, F. C., Krishnan, Y. (2010). Structural DNA nanotechnology: from bases to bricks, from structure to function. Journal of Physical Chemistry Letters, 1, 1994–2005.

Campolongo, M. J., Tan, S. J., Xu, J., Luo, D. (2010). DNA nanomedicine: engineering DNA as a polymer for therapeutic and diagnostic applications. Adv Drug Del Rev, 62, 606–616.

Xiao, Y., & Li, C. M. (2008). Nanocomposites: from fabrications to electrochemical bioapplications. Electroanalytical, 20, 648–662.

Hussain, F., Hojjati, M., Okamoto, M., Gorga, R. E. (2006). Polymer–matrix nanocomposites, processing, manufacturing, and application: an overview. Journal of Composite Materials, 40, 1511–1575.

Rajesh, A. T., & Kumar, D. (2009). Recent progress in the development of nano-structured conducting polymers/nanocomposites for sensor applications. Sensors and Actuators B: Chemistry, 136, 275–286.

Dixit, C. K., & Kaushik, A. (2012). Nano-structured arrays for multiplex analyses and lab-on-a-chip applications. Biochemical and Biophysical Research Communications, 419, 316–320.

Dixit, C.K., Kumar, A., Kaushik, A. (2012). Nanosphere lithography-based platform for developing rapid and high sensitivity microarray systems. Biochemistry and Biophysics Research Communications. doi: 10.1016/j.bbrc.2012.05.144 .

Binnig, G., Quate, C. F., Gerber, C. (1986). Atomic force microscope. Physical Review Letters, 56, 930–933.

http://www.ntmdt.com/spm-principles

Mitsakakis, K., Sekula-Neuner, S., Lenhert, S., Fuchs, H., Gizeli, E. (2012). Convergence of Dip-Pen Nanolithography and acoustic biosensors towards a rapid-analysis multi-sample microsystem. Analyst, 137, 3076–3082.

Mitsakakis, K., Lousinian, S., Logothetidis, S. (2007). Early stages of human plasma proteins adsorption probed by atomic force microscope. Biomolecular Engineering, 24, 119–124.

Florence, A. T. (2004). The dangers of generalization in nanotechnology. Drug Discovery Today, 9, 60–61.

Türk, V., Kaiser, C., Schaller, S. (2008). Invisible but tangible? Societal opportunities and risks of nanotechnologies. Journal of Cleaner Production, 16, 1006–1009.

Wiek, A., Lang, D. J., Siegrist, M. (2008). Qualitative system analysis as a means for sustainable governance of emerging technologies: the case of nanotechnology. Journal of Cleaner Production, 16, 988–999.

Novak, P. J., Arnold, W. A., Blazer, V. S., et al. (2011). On the need for a national (U.S.) research program to elucidate the potential risks to human health and the environment posed by contaminants of emerging concern. Environmental Science and Technology, 45, 3829–3830.

Malloy, T. F. (2011). Nanotechnology regulation: a study in claims making. ACS Nano, 5, 5–12.

Sharifi, S., Behzadi, S., Laurent, S., Forrest, M. L., Stroeve, P., Mahmoudi, M. (2012). Toxicity of nanomaterials. Chemical Society Reviews, 41, 2323–2343.

Oberdörster, G., Oberdörster, E., Oberdörster, J. (2005). Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environmental Health Perspectives, 113, 823–839.

Oberdörster, G. (2005). Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology. Journal of Internal Medicine, 267, 89–105.

Holl, M. M. B. (2009). Nanotoxicology: a personal perspective. WIREs Nanomedicine and Nanobiotechology, 1, 353–359.

Hutchison, J. E. (2008). Greener nanoscience: a proactive approach to advancing applications and reducing implications of nanotechnology. ACS Nano, 2, 395–402.

Leroueil, P. R., Hong, S., Mecke, A., Baker, J. R., Orr, B. G., Holl, M. M. B. (2007). Nanoparticle interaction with biological membranes: does nanotechnology present a Janus face? Accounts of Chemical Research, 40, 335–342.

Marquis, B. J., Love, S. A., Braun, K. L., Haynes, C. L. (2009). Analytical methods to assess nanoparticle toxicity. Analyst, 134, 425–439.

Cui, H. F., Vashist, S. K., Al-Rubeaan, K., Luong, J. H. T., Sheu, F. S. (2010). Interfacing carbon nanotubes with living mammalian cells and cytotoxicity issues. Chemical Research in Toxicology, 23, 1131–1147.

Oberdörster, G., Maynard, A., Donaldson, K., ILSI Research Foundation/Risk Science Institute Nanomaterial Toxicity Screening Working Group, et al. (2005). Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Particle and Fibre Toxicology, 2, 8. doi: 10.1186/1743-8977-2-8 .

Cash, K. J., & Clark, H. A. (2010). Nanosensors and nanomaterials for monitoring glucose in diabetes. Trends in Molecular Medicine, 16, 584–593.

Zheng, D., Vashist, S. K., Al-Rubeaan, K., Luong, J. H. T., Sheu, F. S. (2012). Rapid and simple preparation of a reagentless glucose electrochemical biosensor. Analyst. doi: 10.1039/C2AN35128E .

Dixit, C. K., Vashist, S. K., O’Neill, F. T., O’Reilly, B., MacCraith, B. D., O’Kennedy, R. (2010). Development of a high sensitivity rapid sandwich ELISA procedure and its comparison with the conventional approach. Analytical Chemistry, 82, 7049–7052.

Dixit, C. K., Vashist, S. K., MacCraith, B. D., O’Kennedy, R. (2011). Multi-substrate compatible ELISA procedures for rapid and high sensitivity immunoassays. Nature Protocols, 6, 439–445.

Kostarelos, K., Bianco, A., Prato, M. (2008). Hype around nanotubes creates unrealistic hopes. Nature, 453, 280.

Kotov, N. A. (2009). Politics and nanotechnology in the health care industry. ACS Nano, 3, 2855–2856.